PLOD2 as a potential regulator of peritoneal dissemination in gastric cancer

Yuki Kiyozumi, Masaaki Iwatsuki, Junji Kurashige, Yoko Ogata, Kohei Yamashita, Yuki Koga, Tasuku Toihata, Yukiharu Hiyoshi, Takatsugu Ishimoto, Yoshifumi Baba, Yuji Miyamoto, Naoya Yoshida, Kazuyoshi Yanagihara, Koshi Mimori, Hideo Baba

Research output: Contribution to journalArticle

1 Citation (Scopus)

Abstract

Peritoneal dissemination is the most common metastatic pattern in advanced gastric cancer (GC) and has a very poor prognosis. However, its molecular mechanism has not been elucidated. Our study investigated genes associated with peritoneal dissemination of GC. We performed combined expression analysis of metastatic GC cell lines and identified Procollagen-lysine, 2-oxoglutarate 5-dioxygenase2 (PLOD2) as a potential regulator of peritoneal dissemination. PLOD2 is regulated by hypoxia-inducible factor-1 (HIF-1) and mediates extracellular matrix remodeling, alignment, and mechanical properties. We analyzed PLOD2 expression immunohistochemically in 179 clinical samples, and found high PLOD2 expression to be significantly associated with peritoneal dissemination, leading to poor prognosis. In an in vivo-collected metastatic cell line, downregulation of PLOD2 by siRNA reduced invasiveness and migration. Hypoxia upregulated PLOD2 mediated by HIF-1, and promoted invasiveness and migration. After exposure to hypoxia, a cell line transfected with siPLOD2 exhibited significantly suppressed invasiveness and migration, despite high HIF-1 expression. These findings indicate that PLOD2 is a regulator of, and candidate therapeutic target for peritoneal dissemination of GC. Although peritoneal dissemination of GC has a very poor prognosis, its molecular mechanism has not been elucidated. We identified PLOD2 regulated by HIF-1 as a potential regulator of peritoneal dissemination of GC. Finally, we showed that PLOD2 promotes cell invasiveness and migration in GC under hypoxia and lead to peritoneal dissemination of GC.

Original languageEnglish
Pages (from-to)1202-1211
Number of pages10
JournalInternational Journal of Cancer
Volume143
Issue number5
DOIs
Publication statusPublished - Sep 1 2018

Fingerprint

Procollagen
Lysine
Stomach Neoplasms
Hypoxia-Inducible Factor 1
Cell Line
alpha-ketoglutaric acid
Small Interfering RNA
Cell Movement
Extracellular Matrix
Down-Regulation

All Science Journal Classification (ASJC) codes

  • Oncology
  • Cancer Research

Cite this

Kiyozumi, Y., Iwatsuki, M., Kurashige, J., Ogata, Y., Yamashita, K., Koga, Y., ... Baba, H. (2018). PLOD2 as a potential regulator of peritoneal dissemination in gastric cancer. International Journal of Cancer, 143(5), 1202-1211. https://doi.org/10.1002/ijc.31410

PLOD2 as a potential regulator of peritoneal dissemination in gastric cancer. / Kiyozumi, Yuki; Iwatsuki, Masaaki; Kurashige, Junji; Ogata, Yoko; Yamashita, Kohei; Koga, Yuki; Toihata, Tasuku; Hiyoshi, Yukiharu; Ishimoto, Takatsugu; Baba, Yoshifumi; Miyamoto, Yuji; Yoshida, Naoya; Yanagihara, Kazuyoshi; Mimori, Koshi; Baba, Hideo.

In: International Journal of Cancer, Vol. 143, No. 5, 01.09.2018, p. 1202-1211.

Research output: Contribution to journalArticle

Kiyozumi, Y, Iwatsuki, M, Kurashige, J, Ogata, Y, Yamashita, K, Koga, Y, Toihata, T, Hiyoshi, Y, Ishimoto, T, Baba, Y, Miyamoto, Y, Yoshida, N, Yanagihara, K, Mimori, K & Baba, H 2018, 'PLOD2 as a potential regulator of peritoneal dissemination in gastric cancer', International Journal of Cancer, vol. 143, no. 5, pp. 1202-1211. https://doi.org/10.1002/ijc.31410
Kiyozumi Y, Iwatsuki M, Kurashige J, Ogata Y, Yamashita K, Koga Y et al. PLOD2 as a potential regulator of peritoneal dissemination in gastric cancer. International Journal of Cancer. 2018 Sep 1;143(5):1202-1211. https://doi.org/10.1002/ijc.31410
Kiyozumi, Yuki ; Iwatsuki, Masaaki ; Kurashige, Junji ; Ogata, Yoko ; Yamashita, Kohei ; Koga, Yuki ; Toihata, Tasuku ; Hiyoshi, Yukiharu ; Ishimoto, Takatsugu ; Baba, Yoshifumi ; Miyamoto, Yuji ; Yoshida, Naoya ; Yanagihara, Kazuyoshi ; Mimori, Koshi ; Baba, Hideo. / PLOD2 as a potential regulator of peritoneal dissemination in gastric cancer. In: International Journal of Cancer. 2018 ; Vol. 143, No. 5. pp. 1202-1211.
@article{1160bce490544d1e9eafe7a386b25ea3,
title = "PLOD2 as a potential regulator of peritoneal dissemination in gastric cancer",
abstract = "Peritoneal dissemination is the most common metastatic pattern in advanced gastric cancer (GC) and has a very poor prognosis. However, its molecular mechanism has not been elucidated. Our study investigated genes associated with peritoneal dissemination of GC. We performed combined expression analysis of metastatic GC cell lines and identified Procollagen-lysine, 2-oxoglutarate 5-dioxygenase2 (PLOD2) as a potential regulator of peritoneal dissemination. PLOD2 is regulated by hypoxia-inducible factor-1 (HIF-1) and mediates extracellular matrix remodeling, alignment, and mechanical properties. We analyzed PLOD2 expression immunohistochemically in 179 clinical samples, and found high PLOD2 expression to be significantly associated with peritoneal dissemination, leading to poor prognosis. In an in vivo-collected metastatic cell line, downregulation of PLOD2 by siRNA reduced invasiveness and migration. Hypoxia upregulated PLOD2 mediated by HIF-1, and promoted invasiveness and migration. After exposure to hypoxia, a cell line transfected with siPLOD2 exhibited significantly suppressed invasiveness and migration, despite high HIF-1 expression. These findings indicate that PLOD2 is a regulator of, and candidate therapeutic target for peritoneal dissemination of GC. Although peritoneal dissemination of GC has a very poor prognosis, its molecular mechanism has not been elucidated. We identified PLOD2 regulated by HIF-1 as a potential regulator of peritoneal dissemination of GC. Finally, we showed that PLOD2 promotes cell invasiveness and migration in GC under hypoxia and lead to peritoneal dissemination of GC.",
author = "Yuki Kiyozumi and Masaaki Iwatsuki and Junji Kurashige and Yoko Ogata and Kohei Yamashita and Yuki Koga and Tasuku Toihata and Yukiharu Hiyoshi and Takatsugu Ishimoto and Yoshifumi Baba and Yuji Miyamoto and Naoya Yoshida and Kazuyoshi Yanagihara and Koshi Mimori and Hideo Baba",
year = "2018",
month = "9",
day = "1",
doi = "10.1002/ijc.31410",
language = "English",
volume = "143",
pages = "1202--1211",
journal = "International Journal of Cancer",
issn = "0020-7136",
publisher = "Wiley-Liss Inc.",
number = "5",

}

TY - JOUR

T1 - PLOD2 as a potential regulator of peritoneal dissemination in gastric cancer

AU - Kiyozumi, Yuki

AU - Iwatsuki, Masaaki

AU - Kurashige, Junji

AU - Ogata, Yoko

AU - Yamashita, Kohei

AU - Koga, Yuki

AU - Toihata, Tasuku

AU - Hiyoshi, Yukiharu

AU - Ishimoto, Takatsugu

AU - Baba, Yoshifumi

AU - Miyamoto, Yuji

AU - Yoshida, Naoya

AU - Yanagihara, Kazuyoshi

AU - Mimori, Koshi

AU - Baba, Hideo

PY - 2018/9/1

Y1 - 2018/9/1

N2 - Peritoneal dissemination is the most common metastatic pattern in advanced gastric cancer (GC) and has a very poor prognosis. However, its molecular mechanism has not been elucidated. Our study investigated genes associated with peritoneal dissemination of GC. We performed combined expression analysis of metastatic GC cell lines and identified Procollagen-lysine, 2-oxoglutarate 5-dioxygenase2 (PLOD2) as a potential regulator of peritoneal dissemination. PLOD2 is regulated by hypoxia-inducible factor-1 (HIF-1) and mediates extracellular matrix remodeling, alignment, and mechanical properties. We analyzed PLOD2 expression immunohistochemically in 179 clinical samples, and found high PLOD2 expression to be significantly associated with peritoneal dissemination, leading to poor prognosis. In an in vivo-collected metastatic cell line, downregulation of PLOD2 by siRNA reduced invasiveness and migration. Hypoxia upregulated PLOD2 mediated by HIF-1, and promoted invasiveness and migration. After exposure to hypoxia, a cell line transfected with siPLOD2 exhibited significantly suppressed invasiveness and migration, despite high HIF-1 expression. These findings indicate that PLOD2 is a regulator of, and candidate therapeutic target for peritoneal dissemination of GC. Although peritoneal dissemination of GC has a very poor prognosis, its molecular mechanism has not been elucidated. We identified PLOD2 regulated by HIF-1 as a potential regulator of peritoneal dissemination of GC. Finally, we showed that PLOD2 promotes cell invasiveness and migration in GC under hypoxia and lead to peritoneal dissemination of GC.

AB - Peritoneal dissemination is the most common metastatic pattern in advanced gastric cancer (GC) and has a very poor prognosis. However, its molecular mechanism has not been elucidated. Our study investigated genes associated with peritoneal dissemination of GC. We performed combined expression analysis of metastatic GC cell lines and identified Procollagen-lysine, 2-oxoglutarate 5-dioxygenase2 (PLOD2) as a potential regulator of peritoneal dissemination. PLOD2 is regulated by hypoxia-inducible factor-1 (HIF-1) and mediates extracellular matrix remodeling, alignment, and mechanical properties. We analyzed PLOD2 expression immunohistochemically in 179 clinical samples, and found high PLOD2 expression to be significantly associated with peritoneal dissemination, leading to poor prognosis. In an in vivo-collected metastatic cell line, downregulation of PLOD2 by siRNA reduced invasiveness and migration. Hypoxia upregulated PLOD2 mediated by HIF-1, and promoted invasiveness and migration. After exposure to hypoxia, a cell line transfected with siPLOD2 exhibited significantly suppressed invasiveness and migration, despite high HIF-1 expression. These findings indicate that PLOD2 is a regulator of, and candidate therapeutic target for peritoneal dissemination of GC. Although peritoneal dissemination of GC has a very poor prognosis, its molecular mechanism has not been elucidated. We identified PLOD2 regulated by HIF-1 as a potential regulator of peritoneal dissemination of GC. Finally, we showed that PLOD2 promotes cell invasiveness and migration in GC under hypoxia and lead to peritoneal dissemination of GC.

UR - http://www.scopus.com/inward/record.url?scp=85045837983&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85045837983&partnerID=8YFLogxK

U2 - 10.1002/ijc.31410

DO - 10.1002/ijc.31410

M3 - Article

C2 - 29603227

AN - SCOPUS:85045837983

VL - 143

SP - 1202

EP - 1211

JO - International Journal of Cancer

JF - International Journal of Cancer

SN - 0020-7136

IS - 5

ER -